fda import alert green list glp-1 semaglutide tirzepatide 2025 SFDA updates guidelines for pharmaceutical variation requirements FDA Launches “Green List” to

Some people who developed tinnitus shortly after getting COVID-19 vaccinations are urging the Centers for Disease Control and Prevention to recognize the condition as a potential side effect of the vaccine

The wrong foods exacerbate dryness and create additional oral health risks

* statistically significant Ozone therapy produced a contrary response in the glutathione pathway components to that seen in IgE and HLA-DR

Next, a detailed historical chronology is presented, covering each major GLP-1-based drug: how it was developed, trial results, and its clinical role

Addressing coverage and the high cost associated with Wegovy and other similar drugs, called GLP-1s, is a key concern for insurers, employers and other plan sponsors